News and Community

Ai Drug Discovery, Biomedical Ai, Clinical Development, Drug Development, Drug Discovery Platform, Healthcare Technology, Iambic, Machine Learning, Molecular Ai, Molecular Superintelligence, Multimodal Ai, Pharmaceutical Ai, Preclinical Research

September 22, 2026

Iambic Unveils Enchant v3, a Molecular Superintelligence Platform Built to Power End-to-End Drug Discovery and Development

Agentic Ai, Ai Drug Discovery, Biomarker Discovery, Cancer Research, Clinical Trial Design, Drug Development, Healthcare Technology, K Pro, Multimodal Data, Oncology Ai, Owkin, Pharmaceutical Ai, Precision Medicine

September 14, 2026

Owkin Licenses K Pro and Multimodal Data to Servier for Oncology Research

Biomarkers, Causal Ai, Drug Development, Drug Discovery, Gemini Digital Twins, Healthcare Technology, Neurological Diseases, Therapeutic Targets

September 2, 2026

Ono Pharma Aitia Drug Discovery Partnership Targets Neurological Diseases

Aptar Pharma, Biologics Development, Container Closure Integrity Testing, Drug Delivery Systems, Drug Development, Healthcare Technology, Injectable Therapies, Pharmaceutical Testing, System-level Framework

July 20, 2026

Aptar Pharma Introduces Integrated System-Level Framework for Injectable Drug Development

Ai Biostatistics Platform, Clene Nanomedicine, Clinical Trial Data, Drug Development, Instat, Regulatory Compliance, Veristat

May 14, 2026

Veristat Unveils InStat, an AI Biostatistics Platform to Reduce Clinical Trial Data Readout Time from 5 Weeks to 5 Days Without Regulatory Risks

Ai Immunomodulators, Drug Development, Gen1e, Precision Medicine, Rare Diseases, Strategic Partnership

April 22, 2026

GEn1E and Rubicon Research Forge Strategic Alliance for AI-Powered Precision Immunomodulators Development